Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 5, Issue 1
December 2007
Issue Cover
All Issues
ISSN 1660-2854
EISSN 1660-2862
In this Issue

Neurodegenerative Diseases 2008, Vol. 5, No. 1

Special Section

Title Page / Table of Contents
Neurodegener Dis (2007) 5 (1): 1–3. https://doi.org/10.1159/000112543
View articletitled, Title Page / Table of Contents
Open the PDF for in another window

Introduction

Therapeutic Antibodies in Multiple Sclerosis
Norbert Goebels; Burkhard Becher
Neurodegener Dis (2007) 5 (1): 5–7. https://doi.org/10.1159/000109931
View articletitled, Therapeutic Antibodies in Multiple Sclerosis
Open the PDF for in another window

Original Paper

Intravenous Polyclonal Human Immunoglobulins in Multiple Sclerosis
Per Soelberg Sorensen
Neurodegener Dis (2007) 5 (1): 8–15. https://doi.org/10.1159/000109932
View articletitled, Intravenous Polyclonal Human Immunoglobulins in Multiple Sclerosis
Open the PDF for in another window
Natalizumab: Targeting α4-Integrins in Multiple Sclerosis
Britta Engelhardt; Ludwig Kappos
Neurodegener Dis (2007) 5 (1): 16–22. https://doi.org/10.1159/000109933
View articletitled, Natalizumab: Targeting α<sub>4</sub>-Integrins in Multiple Sclerosis
Open the PDF for in another window
Humanized Anti-CD25 Antibody Treatment with Daclizumab in Multiple Sclerosis
Roland Martin
Neurodegener Dis (2007) 5 (1): 23–26. https://doi.org/10.1159/000109934
View articletitled, Humanized Anti-CD25 Antibody Treatment with Daclizumab in Multiple Sclerosis
Open the PDF for in another window
Campath-1H Treatment of Multiple Sclerosis
Joanne L. Jones; Alasdair J. Coles
Neurodegener Dis (2007) 5 (1): 27–31. https://doi.org/10.1159/000109935
View articletitled, Campath-1H Treatment of Multiple Sclerosis
Open the PDF for in another window
Positive and Negative Implications of Tumor Necrosis Factor Neutralization for the Pathogenesis of Multiple Sclerosis
E. Taoufik; V. Tseveleki; M. Euagelidou; M. Emmanouil; A. Voulgari-Kokota; S. Haralambous; L. Probert
Neurodegener Dis (2007) 5 (1): 32–37. https://doi.org/10.1159/000109936
View articletitled, Positive and Negative Implications of Tumor Necrosis Factor Neutralization for the Pathogenesis of Multiple Sclerosis
Open the PDF for in another window
Preclinical Assessment of Therapeutic Antibodies against Human CD40 and Human Interleukin-12/23p40 in a Nonhuman Primate Model of Multiple Sclerosis
Bert A. ’t Hart; Rogier Q. Hintzen; Jon D. Laman
Neurodegener Dis (2007) 5 (1): 38–52. https://doi.org/10.1159/000109937
View articletitled, Preclinical Assessment of Therapeutic Antibodies against Human CD40 and Human Interleukin-12/23p40 in a Nonhuman Primate Model of Multiple Sclerosis
Open the PDF for in another window

Further Section

Author Index Vol. 5, No. 1, 2008
Neurodegener Dis (2007) 5 (1): 53. https://doi.org/10.1159/000112546
View articletitled, Author Index Vol. 5, No. 1, 2008
Open the PDF for in another window
Subject Index Vol. 5, No. 1, 2008
Neurodegener Dis (2007) 5 (1): 54. https://doi.org/10.1159/000112547
View articletitled, Subject Index Vol. 5, No. 1, 2008
Open the PDF for in another window
Distinct Patterns of Brain Atrophy in Amnestic Mild Cognitive Impairment and Motoric Cognitive Risk Syndromes
Dual-Task Performance and Brain Morphologic Characteristics in Parkinson’s Disease
White Matter Hyperintensities Are Associated with Slower Gait Speed in Older Adults without Dementia
The Impact of Drug Interactions on the Results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes
  • Online ISSN 1660-2862
  • Print ISSN 1660-2854
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal